Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0Y5MF
|
||||
Former ID |
DIB011704
|
||||
Drug Name |
BND-001
|
||||
Synonyms |
BND-001; NiK-001; NiK-10001; NiK-10034; NiK-18862; Nik-21273; ORL-1 antagonists (CNS disorders); ORL-1 antagonists (CNS disorders), Brane; Opioid receptor like-1 antagonists (CNS disorders), NiKem Research
|
||||
Indication | Central nervous system disease [ICD10:G00-G99] | Investigative | [1] | ||
Company |
NiKem Research Srl
|
||||
Structure |
![]() |
Download2D MOL |
|||
Canonical SMILES |
C(=O)(Cn1c(c(c2ccccc12)CN1CCC(CC1)c1c(cccc1F)Cl)C(=O)N1<br />CCOCC1)N
|
||||
Target and Pathway | |||||
Target(s) | Nociceptin receptor | Target Info | Antagonist | [1] | |
KEGG Pathway | Neuroactive ligand-receptor interaction | ||||
PANTHER Pathway | Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | ||||
Heterotrimeric G-protein signaling pathway-Gq alpha and Go alpha mediated pathway | |||||
Reactome | Peptide ligand-binding receptors | ||||
G alpha (i) signalling events | |||||
WikiPathways | GPCRs, Class A Rhodopsin-like | ||||
Peptide GPCRs | |||||
GPCR ligand binding | |||||
GPCR downstream signaling | |||||
References | |||||
REF 1 | (http://www.guidetopharmacology.org/) Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Target id: 320). | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.